|
| |
| |
|
|
Fibrocell Announces Exclusive License with UCLA
Technologies from the UCLA collaboration and exclusive license agreements enable Fibrocell to expand its proprietary Personalized Biologics platform which uses human fibroblasts and stem cells from skin to create localized therapies that are compatible with the unique biology of each patient. |
|
|
|
UCLA Startup, Kite Pharma, Raises $128M in IPO
Kite Pharma, Inc., a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT™) products for the treatment of cancer, announced the pricing of its IPO of 7,500,000 shares of its common stock at a price to the public of $17.00 per share.
|
|
|
CytoVale Raises $4.3M Series A for Early Sepsis Detection
UCLA startup licensee, CytoVale Inc . has raised a $4.3 million Series A round to better-enable early detection of sepsis, a severe response to infection that leads to organ damage, deaths, and billions of dollars in health-care expenses. |
|
|
|
Intellectual Property Announcements
New U.S. Patents Awarded
-
8,759,296 - Bone morphogenic protein binding peptide | S. Murray, et al.
-
8,759,006 - PSCA: prostate stem cell antigen and distinguishing androgen. . . | R. Reiter, et al.
-
8,755,493 - Apparatus for producing X-rays for use in imaging | G. Travish, et al.
-
8,754,034 - Structure-based design of peptide inhibitors of amyloid fibrillation | D. Eisenberg, et al.
-
8,753,660 - Activating extraction of demineralized bone matrix | S. Murray, et al.
-
8,742,152 - Preparation of metal-catecholate frameworks | O. Yaghi, et al.
-
8,742,139 - No-carrier-added nucleophilic [F-18] fluorination of aromatic compounds | J. Barrio, et al.
-
8,741,306 - Kidney specific tumor vaccine directed against kidney tumor. . . | A. Belldegrun, et al.
~~~~
New UCLA Technologies Available for Licensing
SEARCH MORE TECHNOLOGIES
~~~~
|
|
|
|
| From Our Previous Issue |
- UC FY13 Report on Tech-Transfer: UCLA #1 in Startups
- UCLA Startup, ImaginAb, Raises $21 Million in Series B Financing
- UCLA Innovation Featured at UC Tech Commercialization Forum
- Roundup: UCLA Startup Funding & IP Licensing Highlights
- View More
|
|
|
|
Career Opportunities at UCLA Startups
C3 Jian
- Research Associate (Microbiology and Diagnostics)
- Laboratory Assistant
ImaginAb
- Vice President, Clinical Development
- Senior Research Associate - Conjugation Chemistry and Process Development
- Staff Research Associate I
Kite Pharma
- Sr. Process Engineer
- Research Associate, Cell Culture
- Director, Quality Assurance
|
|
|
|
"I recently attended the UCLA Medical Device partnership conference. I am interested
in directed research with UCLA research groups." - Sr. R&D Manager
UCLA TechMatch
UCLA's customized, automated TechMatch service connects UCLA innovation with
industry research and technology licensing interests.
Subscribe today.
|
|
|
|
|
|
UCLA Invents Newsletter, Vol. 2, No. 11
How to Subscribe:
http://oip.ucla.edu/UCLAinvents
View Newsletter Archive
Send editorial comments and corrections to:
Bob Nidever, Editor, bnidever@research.ucla.edu
Contributors: Neil Bajpayee, Ben Dibling, Howard Chang, Miles Gerson
UCLA Invents is published by the UCLA Office of Intellectual Property & Industry Sponsored Research
11000 Kinross Ave., Suite 200; Los Angeles, CA 90095 | tel. 310-794-0558 | http://oip.ucla.edu
Copyright © 2014 The Regents of the University of California. All Rights Reserved.
|
|
|
|
